Bailard’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$888K Buy
+22,000
New +$864K 0.02% 397
2025
Q3
Sell
-26,100
Closed -$799K 811
2025
Q2
$799K Buy
26,100
+1,000
+4% +$28.8K 0.02% 366
2025
Q1
$717K Sell
25,100
-4,900
-16% -$132K 0.02% 371
2024
Q4
$812K Hold
30,000
0.02% 331
2024
Q3
$926K Hold
30,000
0.02% 320
2024
Q2
$753K Buy
30,000
+19,800
+194% +$490K 0.02% 345
2024
Q1
$249K Sell
10,200
-638
-6% -$14.4K 0.01% 626
2023
Q4
$243K Sell
10,838
-7,562
-41% -$167K 0.01% 621
2023
Q3
$377K Buy
18,400
+7,100
+63% +$144K 0.01% 474
2023
Q2
$224K Sell
11,300
-5,000
-31% -$97.7K 0.01% 609
2023
Q1
$319K Buy
16,300
+6,300
+63% +$123K 0.01% 495
2022
Q4
$186K Hold
10,000
0.01% 660
2022
Q3
$181K Hold
10,000
0.01% 610
2022
Q2
$184K Buy
+10,000
New +$177K 0.01% 617
2019
Q4
Sell
-14,000
Closed -$329K 553
2019
Q3
$329K Buy
14,000
+1,600
+13% +$37.6K 0.02% 380
2019
Q2
$295K Buy
+12,400
New +$300K 0.02% 417

Other funds holding CTRE

Bailard's CTRE Position: Q2 2026 in Review

Bailard opened a new position in CareTrust REIT (CTRE) in Q2 2026: 22,000 shares worth $888K. The stake represents 0.02% of the portfolio and ranks #397 among its holdings. This is a return to the name: Bailard previously reported a position in CTRE as recently as Q2 2025.

Bailard first reported a position in CTRE in Q2 2019 and has held it in 16 quarters since. The position peaked at $926K in Q3 2024. 516 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Bailard held 22,000 shares of CareTrust REIT worth $888K as of Q2 2026.
  • CareTrust REIT was a new Bailard position in Q2 2026.
  • CareTrust REIT made up 0.02% of Bailard's portfolio in Q2 2026, its #397 holding.
  • Bailard first reported a position in CareTrust REIT in Q2 2019 and has held it in 16 quarters since.
  • Bailard's CareTrust REIT position peaked at $926K in Q3 2024.
  • 516 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.